How MSD is responding to the global pandemic, COVID-19

Save Print

March 23, 2020 8:50 pm +00:00

How MSD is responding to the global pandemic, COVID-19

Around the world, our objectives remain the same: To protect the safety of our employees and to produce and supply our essential medicines and vaccines for those who need them. That is our unique responsibility as a company, and we factor that responsibility into every decision we make.

Thanks to our colleagues, our manufacturing plants and clinical supply sites remain open around the world and, we are taking steps to make sure that continues to be the case. Our thoughts are with the people of all affected areas. We would also like to extend our sincere appreciation to the many health care providers and volunteers who are doing so much to help affected patients and communities. 

We know many of you have questions and we want to answer them as best as we can. To help you navigate your questions, we’re providing the list of FAQs below:

Does MSD have medicines or vaccines for COVID-19? If not, is MSD developing any medicines and vaccines to help combat COVID-19?

MSD makes a range of medicines and vaccines for infectious diseases, but none of them are approved for use to treat COVID-19. As a science-driven company that aims to address some of the world’s biggest health care challenges, we are carefully monitoring the situation. Our Global company have established a team of scientists to assess internally available antiviral candidates and vaccine assets for potential to impact SARS-coV-2 and related viruses.

How is COVID-19 impacting MSD clinical trials?

Driven by our steadfast commitment to patients, we are making every effort to ensure that patients in affected areas who are enrolled in clinical trials are able to continue their treatment and receive appropriate care and monitoring.

How are you keeping employees safe from COVID-19?

We continue to make decisions that are aligned with UK Government and NHS recommendations and in the best interests of our employees, patients and customers. Our colleagues who can work from home are working from home. We are also asking all employees to follow global health recommendations on handwashing and social distancing, if experiencing symptoms of fever, shortness of breath to stay home – this applies during this outbreak – and is a good practice at any time.

How do we reach the media team at MSD?

If you have an inquiry and would like to reach our media team, please email externalaffairs_UK@msd.com.

How can we stay up to date on COVID-19?

We know there’s a lot of information about COVID-19. We recommend visiting NHS UK for health information and advice and GOV.UK to learn about the government response to coronavirus.


Up to date information for Healthcare Practitioners regarding UK supply of Pharmaceutical Products and Vaccines can be found here.

About MSD

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programmes and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.

GB-NON-02531 | Date of Preparation: 20 March 2020